Robert A. Gabbay, MD, PhD, FACP, is Chief Medical Officer and Senior Vice President at Joslin Diabetes Center, and Associate Professor at Harvard Medical School. He is oversees the clinical care for over 25,000 patients at Joslin in Boston, as well as the education and care programs Joslin delivers nationally and internationally. His research focuses on innovative models of diabetes care to improve to enhance diabetes outcomes and patients’ experiences. To improve quality, he has traversed many arenas including better patient communication tools, creating the first broad scale diabetes registry, designing and implementing a care management training program, leading Pennsylvania’s statewide implementation of the Patient Centered Medical Home (PCMH), and defining the medical neighborhood and the role of centers of excellence. Dr. Gabbay has received funding from the National Institute of Health Diabetes, Digestive and Kidneys Diseases (NIDDK), the Agency for Healthcare Research and Quality (AHRQ), and the Center for Medicare and Medicaid Innovation for his care transformation work.

Dr. Gabbay completed his Bachelor’s Degree at McGill University and his PhD in Biochemistry from the University of Wisconsin, and his medical degree from the State University of New York at Brooklyn School of Medicine with a residency in internal Medicine at New York Hospital-Cornell and fellowship in Endocrinology, Diabetes and Metabolism at a joint Joslin-Beth Israel Deaconess-Brigham and Women’s Hospital program. Dr. Gabbay was a visiting scientist at MIT and a Professor of Medicine at Pennsylvania State University College of Medicine.

Dr. Gabbay’s focus at Joslin Diabetes Center is to foster innovation within the walls of Joslin, as well as disseminating these approaches regionally, nationally, and internationally. While in Pennsylvania Dr. Gabbay was dedicated to creating a model for the Patient-Centered Medical Neighborhood for diabetes, a compliment to his PCMH research. Dr. Gabbay has led one of the first large medical home pilots across 150 practices and 80,000 patients with diabetes. Dr. Gabbay’s interventions include behavior change using motivational interviewing, self-management support, decision support, technology, population health, medical neighborhood, care management, and digital health. His efforts leading a culture of quality and implementing medical neighborhood principles, has resulted in Joslin becoming one of the first diabetes programs nationally to receive National Committee for Quality Assurance (NCQA) recognition as a patient centered specialty practice (an analog of the medical neighborhood) and continued outcome based NCQA recognition for Joslin’s  education program and providers. Longstanding programs such as the Joslin Clinical Guidelines are being published and more broadly disseminated. 

The reach of his work has been recognized through leadership roles in national and international activities to transform diabetes care including chairing the Endocrine Society’s Task Force for Innovative Models of Diabetes Care and leading the International Diabetes Federation BRIDGES program that implements evidence based translational research to low resource global settings and chairing the American Diabetes Association Practice Optimization Task Force. Dr. Gabbay has served as visiting professor, keynote speaker and organizing committees for global meetings of International Diabetes Federation, American Diabetes Association, Endocrine Society, and the Diabetes Technology Society. Along with an extensive peer reviewed publication record, his views a have appeared in popular press such as the New York Times, CNN, Oprah, the Washington Post and NPR.

Dr. Gabbay is dedicated to providing the best quality possible to diabetes patients while exceeding the highest national clinical quality measures. Through these innovative care delivery models he and Joslin are committed to providing solutions to providers, health systems, payer, governmental agencies or employers ultimately to improve the lives of those with diabetes. 

Medical School
The State University of New York at Brooklyn School of Medicine

Residency
Residency in Internal Medicine, New York Hospital – Cornell University Medical Center, New York, NY 1990-1993; Chief Resident, Department of Medicine, New York Downtown Hospital, New York, New York 1993-1994

Fellowship
Endocrinology and Metabolism Fellowship, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 1994-1997

Certification
American Board of Internal Medicine, Subspecialty Certification in Endocrinology and Medicine

  • Adult

Contact Information

Office Phone

(617) 309-2501

robert.gabbay [at] joslin.harvard.edu

News Related to Robert Gabbay

Doctor close up with arms crossed
Type 1
Type 2

Joslin Physicians on Boston Magazine's Top Docs List

Joslin Physicians on Boston Magazine's Top Docs List

Eleven of Joslin's physicians have made Boston Magazine’s 2020 Top Doctors List. Each year, Boston Magazine partners with healthcare researcher Castle Connolly Medical Ltd. to create a list of the...
Read more on Joslin Physicians on Boston Magazine's Top Docs List
Group image of Young Adult conference attendees
Young Adult

Caring for Young Adults with Diabetes Conference

Caring for Young Adults with Diabetes Conference

Diabetes care delivery and management continue to be challenging when it comes to young adults. According to the most recent T1D Exchange data, the mean A1C among young adults is above goal and...
Read more on Caring for Young Adults with Diabetes Conference
Woman checking glucose level with a remote sensor and mobile phone, sensor checkup glucose levels without blood, good result. Diabetes treatment.
Managing Diabetes
Technology
Type 1
Research Highlights

The diabetes pandemic and the promise of connected care

The diabetes pandemic and the promise of connected care

BOSTON – (October 3, 2019) – Digital diabetes management systems (“connected diabetes care”) have the potential to become part of a new diabetes care model, augmenting the traditional practice of...
Read more on The diabetes pandemic and the promise of connected care